Don’t miss the latest developments in business and finance.

Zydus receives USFDA final approval for Clobetasol Propionate Cream

Image
Capital Market
Last Updated : Oct 17 2018 | 3:05 PM IST
Cadila Healthcare has received final approval from USFDA to market Clobetasol Propionate Cream, (US RLD Temovate Cream), 0.05%. It will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.

Clobetasol Propionate is a topical (for the skin) steroid used to treat inflammation and itching caused by a number of skin conditions such as allergic reactions, eczema, and psoriasis.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Oct 17 2018 | 2:17 PM IST

Next Story